Predictors of malignant potential of cystic lesions of the pancreas
Introduction
Cystic lesions of the pancreas (CLP) are increasingly being recognized due to more awareness and the widespread use of abdominal cross-sectional imaging.1, 2, 3 Although approximately 90% of cystic masses are pancreatitis-associated pseudocysts, the remaining lesions are neoplasms of varying histology.1, 4 Recent reviews have revealed that CLP are very variable in their morphology, clinical behaviour and pathogenesis.5, 6 Kosmahl et al. have recently proposed an extensive histopathological classification of pancreatic cystic neoplasms and tumour-like lesions with cystic features.7 This classification includes neoplastic and non-neoplastic lesions of epithelial and non-epithelial origin. The main differential diagnoses are benign lesions such as pancreatitis-associated pseudocysts and inflammatory cysts, neoplasms with malignant potential such as mucinous neoplasms and solid pseudo-papillary neoplasms, and malignancy such as intraductal papillary-mucinous carcinoma and invasive ductal adenocarcinoma.
In the clinical setting, it is crucial to differentiate between a benign and malignant CLP as the management of these conditions is entirely different. Due to the malignant potential of certain cystic neoplasms and the potential cure following surgery, current recommendations suggest that patients with CLP should undergo curative resection if feasible.8, 9, 10 Failure to accurately characterize CLP can lead to inappropriate treatment.11 Misdiagnosing cystic neoplasms as pancreatic pseudocysts is not uncommon, and in one series this occurred in 33% of cases.1 Therefore, the ability to differentiate benign, pre-malignant and malignant lesions based on clinical presentation, biochemistry, and/or radiological imaging is important.
The aim of the current study was to identify predictors of neoplastic potential in CLP at the time of presentation, to determine which patients should undergo further investigation and/or surgery.
Section snippets
Demographic data
Patients diagnosed with CLP at the Leeds Teaching Hospitals (LTH) NHS Trust during the 11-year period, from January 1995 to December 2005, were identified using the hospital's pathology database and radiology computer coding system (Radiology Management System - RMS). The RMS search identified patients with a cystic lesion of the pancreas stated in radiology reports, which included abdominal ultrasonography (USS), computer tomography (CT), magnetic resonance imaging of the pancreas (MRI),
Demographic data
During the study period, 121 patients with CLP were identified, of which 79 patients were included. Thirty-one patients with chronic pancreatitis, eight patients with von-Hippel Lindau disease and three patients with a recent history of acute pancreatitis were excluded from the study. There were 27 men and 52 women, and the median age at diagnosis was 68 years (range: 31–92 years).
Forty-eight patients presented with abdominal pain, 17 patients with jaundice, and 27 patients with weight loss.
Discussion
The management of CLP is still highly debatable and largely depends on accurate characterisation of the underlying pathology. Although an aggressive resectional approach is recommended by some authors,10 many clinicians still question this policy in light of an increasing number of CLP being identified incidentally.12, 13
Conclusion
In conclusion, cyst size is an independent predictor of malignant potential of CLP. CLP with malignant characteristics are more likely to present with symptoms, such as jaundice. For cystic lesions less than 2.5 cm in size in the head of the pancreas, abnormal liver function tests and/or the presence of biliary duct dilatation is associated with malignant potential.
Conflict of interest
The authors have no conflict of interest.
References (40)
- et al.
Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature
Gastroenterology
(1996) - et al.
Cystic lesions and neoplasms of the pancreas. The features are becoming clearer
Pancreatology
(2001) - et al.
Intraductal papillary and mucinous tumors of the pancreas: accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series
Gastrointest Endosc
(1998) - et al.
An aggressive resectional approach to cystic neoplasms of the pancreas
Am J Surg
(1999) - et al.
Cystic neoplasms of the pancreas with mucin-production
Eur J Surg Oncol
(2005) - et al.
Cystic lesions of the pancreas: selection criteria for operative and nonoperative management in 209 patients
J Gastrointest Surg
(2003) - et al.
Cystic pancreatic neoplasms: enucleate or resect?
J Gastrointest Surg
(2003) - et al.
Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas?
Am J Gastroenterol
(2001) - et al.
Utility of EUS in the evaluation of cystic pancreatic lesions
Gastrointest Endosc
(2002) - et al.
Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions
Am J Gastroenterol
(2003)